The first 90 days after an Inspire implant

The implant is not the treatment until it is turned on. In STAR, the device stayed off for about a month while the wounds healed, then it was activated after a repeat sleep study, then stimulation was raised at home and again in the lab. Residual AHI is expected. This article describes that published pathway. It is not Dr. Qadoom’s personal protocol, and any local timing should be treated as unverified until the surgical team writes it down.

Why is the stimulator off after surgery?

STAR’s methods are explicit. About one month after implantation, every participant had a second baseline diagnostic polysomnography before the device was activated. Immediately after that study, the device was turned on and patients were taught to start and stop therapy with a controller each night. The month of silence is for healing and for a clean pre-activation AHI, not because the implant “needs to settle” as a marketing phrase.

What you feel in those weeks is incision pain, swelling, and the oddness of a generator under the skin. STAR reported two serious device-related events that required repositioning of the neurostimulator for discomfort. No permanent tongue weakness was reported in the 12-month paper. Tongue soreness, abrasion, and temporary weakness appear in later clinical-pathway papers as ordinary early complaints. None of those sentences is a promise that your recovery will be quiet. Call for fever, expanding hematoma, or a wound that opens. this practice’s after-hours surgical coverage and the exact day you are allowed to shower, drive, and raise the arm on the implant side.

Do not turn the remote on early because a forum said someone did. Stimulation on a fresh nerve cuff is not a home experiment.

What happens on activation day?

In STAR, activation followed the one-month diagnostic PSG the same day. You learn which button starts therapy, which stops it, and that the system typically waits after you turn it on so you can fall asleep first. Medicare LCD background text describes a 20-minute delay on the system it reviews. That is LCD description of a device generation, not a setting this office has confirmed for Inspire V. the delay programmed for your generator.

The first sensations are twitching, tingling, or a tug in the tongue that can wake you. That is the point of a low starting amplitude. Mayo Clinic’s clinical summary of the STAR-style pathway tells patients to use the device nightly and slowly self-titrate stimulation over a limited range for about a month. Woodson’s three-year STAR follow-up paper says the same: during the first month of home use after activation, participants gradually increased stimulation for acclimatization to functional stimulation.

If the tongue fires so hard you cannot sleep, turn the amplitude down within the range you were given and call. If you feel nothing, do not assume the implant failed. The functional threshold is often below the amplitude that stops apneas. Titration in the lab is still ahead.

When is the titration sleep study?

STAR scheduled polysomnography at months 2, 6, and 12 after implant, with clinic visits also at months 3 and 9. During the 2-month and 6-month studies, engineers and physicians adjusted voltage, rate, pulse width, and timing with a programmer. No adjustments were allowed in the 30 days before or during the 12-month study, because that night was the efficacy readout, not a tuning session.

Woodson et al. (36-month STAR outcomes) state that between two and six months, one or more in-lab titration studies were done, with extra titrations after six months if earlier nights and patient feedback said they were needed. A 2017 clinical-pathway paper (Vanderveken and colleagues) describes the formal titration night as roughly two months after surgery: amplitude is raised slowly so the airway can stabilize after events, then the patient goes home with a narrow range around the therapeutic setting (they describe therapeutic amplitude ± 0.2 volts in five steps). Those volts are from that pathway paper, not from a Westerville order set. how many titration nights this surgeon and this sleep lab actually book, and whether Inspire V’s programmer uses the same step size.

The titration night is an attended sleep study. You will be wired as usual. Someone in the control room changes stimulation when apneas persist or when you arouse from the pulse. Morning residual AHI on that night is a titration AHI, which is often lower than a full-night AHI on a fixed setting. STAR’s 12-month number was a full-night study without recent tinkering. Do not compare your 2-month titration printout to STAR’s 9.0 and declare victory or failure.

What residual AHI should you expect?

STAR’s median AHI at 12 months was 9.0 events per hour, down from 29.3. Median ODI went from 25.4 to 7.4. Sixty-six percent (83 of 126) met the coprimary AHI definition: at least a 50% drop and AHI under 20. That means one in three did not. The trial counted dropouts as non-responders. Turning the device off for a week in the withdrawal substudy sent mean AHI back up (25.8 versus 7.6 in the group that stayed on). The implant does not remodel the airway into a cure. It reduces obstructive events while it is on and while the settings match your anatomy.

If your 90-day residual AHI is still in the 20s, the next moves in published pathways are more titration, a look at electrode configuration, a check that you are using the device, and a repeat DISE in selected non-responders. None of those is automatic here. local non-responder protocol.

Symptoms can improve before the integer does, and the integer can look better than you feel. Epworth and FOSQ were secondary outcomes in STAR and did improve at 12 months. Bring the sleepiness scale to follow-up rather than asking the programmer to “turn it up until I feel cured.”

What does a STAR-style first 90 days look like on a calendar?

Week 0: implant. Weeks 1 to 4: wounds, no stimulation, then the pre-activation PSG and teaching. Weeks 5 to 8: nightly use, home self-titration in a tight range, clinic interrogation of the generator. Around month 2: attended titration PSG. Month 3: STAR had an outpatient visit for adverse events and device interrogation without a required PSG. That is 90 days. The 6-month and 12-month studies sit outside this window and still matter. Five-year STAR follow-up (Woodson 2018) found an AHI responder rate of 75% among 71 people who volunteered for a PSG, and 63% using last-observation-carried-forward. Long-term numbers are not the first 90 days, but they are why you should not judge the implant on week five.

Hours of use can be read from the generator at follow-up. STAR’s 12-month self-reported daily use was 86%. A device that is off in the drawer is not failing. It is unused. If stimulation arousals are the reason it is off, that is a programming visit, not a character test.

What this article is not

It is not an eligibility essay. AHI windows, BMI, and DISE belong in the qualification article. It is not a promise of this surgeon’s incision count, Inspire V versus older sensing-lead anatomy, or your personal activation date. Inspire V, Model 3150, was approved 1 August 2024. Whether your implant is that generator is in the operative note.

Questions about Inspire therapy after surgery go to the team that implanted you and to the sleep physician who will read the titration study. For Westerville Sleep Center, call (614) 898-9340 during Monday through Friday, 8:00 AM to 5:00 PM. The office is at 450 Alkyre Run Drive, Suite 230. If the problem is a wound, say so on the phone. If the problem is residual snoring at week six, say that too; the answer may be “wait for titration,” which is a STAR-shaped answer, not a brush-off. Contact the same number rather than sending clinical detail through a web form.